| Symbol |
Name |
|
ATR
|
ATR serine/threonine kinase
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BRCA1
|
breast cancer 1, early onset
|
|
CANX
|
calnexin
|
|
CCNA1
|
cyclin A1
|
|
CCNB1
|
cyclin B1
|
|
CCNB2
|
cyclin B2
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC34
|
cell division cycle 34
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CUL1
|
cullin 1
|
|
DHFR
|
dihydrofolate reductase
|
|
EDEM1
|
ER degradation enhancer, mannosidase alpha-like 1
|
|
ELAC1
|
elaC ribonuclease Z 1
|
|
EP300
|
E1A binding protein p300
|
|
ESR1
|
estrogen receptor 1
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCC
|
Fanconi anemia, complementation group C
|
|
FANCE
|
Fanconi anemia, complementation group E
|
|
FANCF
|
Fanconi anemia, complementation group F
|
|
FANCG
|
Fanconi anemia, complementation group G
|
|
FBXO2
|
F-box protein 2
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GANAB
|
glucosidase, alpha; neutral AB
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HDAC9
|
histone deacetylase 9
|
|
LEMD3
|
LEM domain containing 3
|
|
MAN2A2
|
mannosidase, alpha, class 2A, member 2
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MOGS
|
mannosyl-oligosaccharide glucosidase
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MYT1
|
myelin transcription factor 1
|
|
NECAB3
|
N-terminal EF-hand calcium binding protein 3
|
|
PCMTD2
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2
|
|
PLK1
|
polo-like kinase 1
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1
|
|
RB1
|
retinoblastoma 1
|
|
RBX1
|
ring-box 1, E3 ubiquitin protein ligase
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
SAE1
|
SUMO1 activating enzyme subunit 1
|
|
SEC61A1
|
Sec61 alpha 1 subunit (S. cerevisiae)
|
|
SFN
|
stratifin
|
|
SKP1
|
S-phase kinase-associated protein 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SMAD3
|
SMAD family member 3
|
|
SMURF1
|
SMAD specific E3 ubiquitin protein ligase 1
|
|
TFDP1
|
transcription factor Dp-1
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TP53
|
tumor protein p53
|
|
TRIM25
|
tripartite motif containing 25
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
UGGT1
|
UDP-glucose glycoprotein glucosyltransferase 1
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
YWHAH
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta
|
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
|
ZNF276
|
zinc finger protein 276
|